| 英文別名： |
CP 690550;3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile;Tofacitinib CP690550 Tasocitinib;Tofacitinib citrate;(3R,4R)-4-methyl-3-(methyl-1H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-b-oxo-, (3R,4R)-;1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, (...;3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-oxopiperidin-1-yl)propanenitrile;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile(CP-690550);CP 690550 Tofacitinib;CP-690550;oxopropanenitrile;Tasocitinib;Tasocitinib-CP690550;Tofacitinib;Tofacitinib (CP-690550,Tasocitinib) |
| 中文別名： |
3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-d]嘧啶-4-基)氨基)哌啶-1-基)-3-氧代丙腈;1,4-二氯-2,5-二甲氧基苯;13C、15N和2H氘同時(shí)標(biāo)記的標(biāo)準(zhǔn)品;3-((3R,4R)-4-甲基-3-(甲基(7H-吡咯并[2,3-d]嘧啶-4-基)氨基派啶-1-基)-3-氧代丙腈;CP 690550（托法替尼）;他索西替尼 ,托法替尼;托法替布;托法替尼;托法替尼 新藥技術(shù)轉(zhuǎn)讓;托法替尼(Tofacitinib,CP-690550);托法替尼堿;托法替尼堿CP 690550 |
.png)
滬公網(wǎng)安備 31011502020044號(hào)
危險(xiǎn)化學(xué)品經(jīng)營(yíng)許可證
水濤